- Home
- IDCC vs AXSM Comparison
IDCC vs AXSM Comparison
Compare IDCC & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IDCC
- AXSM
- Stock Information
- Founded
- IDCC 1972
- AXSM 2012
- Country
- IDCC United States
- AXSM United States
- Employees
- IDCC N/A
- AXSM N/A
- Industry
- IDCC Multi-Sector Companies
- AXSM Biotechnology: Pharmaceutical Preparations
- Sector
- IDCC Miscellaneous
- AXSM Health Care
- Exchange
- IDCC Nasdaq
- AXSM Nasdaq
- Market Cap
- IDCC 5.6B
- AXSM 5.1B
- IPO Year
- IDCC N/A
- AXSM 2015
- Fundamental
- Price
- IDCC $215.91
- AXSM $107.06
- Analyst Decision
- IDCC Strong Buy
- AXSM Strong Buy
- Analyst Count
- IDCC 1
- AXSM 15
- Target Price
- IDCC $160.00
- AXSM $170.20
- AVG Volume (30 Days)
- IDCC 277.7K
- AXSM 612.2K
- Earning Date
- IDCC 05-01-2025
- AXSM 05-05-2025
- Dividend Yield
- IDCC 0.87%
- AXSM N/A
- EPS Growth
- IDCC 84.98
- AXSM N/A
- EPS
- IDCC 12.66
- AXSM N/A
- Revenue
- IDCC $815,481,000.00
- AXSM $432,157,000.00
- Revenue This Year
- IDCC N/A
- AXSM $63.30
- Revenue Next Year
- IDCC N/A
- AXSM $61.15
- P/E Ratio
- IDCC $17.16
- AXSM N/A
- Revenue Growth
- IDCC 33.52
- AXSM 72.16
- 52 Week Low
- IDCC $111.85
- AXSM $64.11
- 52 Week High
- IDCC $231.97
- AXSM $139.13
- Technical
- Relative Strength Index (RSI)
- IDCC 55.46
- AXSM 50.87
- Support Level
- IDCC $210.88
- AXSM $101.41
- Resistance Level
- IDCC $217.91
- AXSM $106.77
- Average True Range (ATR)
- IDCC 5.03
- AXSM 3.01
- MACD
- IDCC -0.39
- AXSM 0.01
- Stochastic Oscillator
- IDCC 48.48
- AXSM 67.83
About IDCC InterDigital Inc.
InterDigital Inc is a research and development company focused on wireless, video, Artificial Intelligence, and related technologies. It designs and develops technologies that enable connected, immersive experiences in a broad range of communications and entertainment products and services. The majority of revenue is generated from fixed-fee patent license agreements, with a smaller portion coming from variable royalty agreements. Geographically it operates in the United States, China, South Korea, Japan, Taiwan, and Europe, out of which the majority is from China.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.